Physician profile
Mohammad Hashim Jilani
NPI 1992226393
$2,441.51
in general payments reported to CMS, 2019-2025
17 companies · $608 in 2025
The $608 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $229 · 2023: $433 · 2024: $920 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352 · Education: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.38 |
| Education | $609.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $399.06 | 2023-2024 | Onyx Frontier |
| Aop Health US, LLC | $354.49 | 2025 | Rapiblyk |
| Teleflex LLC | $312.51 | 2023-2025 | Guideliner, Turnpike |
| Shockwave Medical, INC | $246.98 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $238.14 | 2021-2024 | Brilinta |
| Boston Scientific Corporation | $159.71 | 2024 | |
| Livanova USA, INC. | $149.20 | 2022 | |
| Novo Nordisk INC | $100.43 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.48 | 2021-2024 | Lifevest |
| Chiesi USA, INC. | $85.60 | 2024-2025 | Kengreal, Juxtapid |
| Angiodynamics, INC. | $68.88 | 2025 | Angiovac |
| Reflow Medical INC | $66.25 | 2024 | |
| Stryker Corporation | $58.93 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $49.65 | 2022-2025 | |
| Abiomed | $22.09 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $17.83 | 2023 | Cardiosave Hybrid, Type B Plug |
| Janssen Pharmaceuticals, INC | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hashim Jilani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.